Suivre
Miguel Henriques Abreu, MD, PhD
Miguel Henriques Abreu, MD, PhD
Portuguese Institute of Oncology of Porto
Adresse e-mail validée de sapo.pt
Titre
Citée par
Citée par
Année
Missing data imputation on the 5-year survival prediction of breast cancer patients with unknown discrete values
PJ García-Laencina, PH Abreu, MH Abreu, N Afonoso
Computers in biology and medicine 59, 125-133, 2015
1492015
Predicting breast cancer recurrence using machine learning techniques: a systematic review
PH Abreu, MS Santos, MH Abreu, B Andrade, DC Silva
ACM Computing Surveys (CSUR) 49 (3), 1-40, 2016
912016
The prevalence of acne in the north of Portugal
JM Amado, ME Matos, AM Abreu, L Loureiro, J Oliveira, A Verde, A Massa
Journal of the European Academy of Dermatology and Venereology 20 (10), 1287 …, 2006
872006
Diode laser surgery versus scalpel surgery in the treatment of fibrous hyperplasia: a randomized clinical trial
MBF Amaral, JMS De Ávila, MHG Abreu, RA Mesquita
International journal of oral and maxillofacial surgery 44 (11), 1383-1389, 2015
602015
Male breast cancer: Looking for better prognostic subgroups
MH Abreu, N Afonso, PH Abreu, F Menezes, P Lopes, R Henrique, ...
The Breast 26, 18-24, 2016
492016
Practical clinical guidelines of the EOTTD for treatment and referral of gestational trophoblastic disease
C Lok, N van Trommel, L Massuger, F Golfier, M Seckl, MH Abreu, J Attia, ...
European Journal of Cancer 130, 228-240, 2020
352020
Overall survival prediction for women breast cancer using ensemble methods and incomplete clinical data
PH Abreu, H Amaro, DC Silva, P Machado, MH Abreu, N Afonso, ...
XIII Mediterranean Conference on Medical and Biological Engineering and …, 2014
282014
Patterns of recurrence and treatment in male breast cancer: A clue to prognosis?
M Henriques Abreu, P Henriques Abreu, N Afonso, D Pereira, R Henrique, ...
International Journal of Cancer 139 (8), 1715-1720, 2016
172016
CYP2D6* 4 polymorphism: A new marker of response to hormonotherapy in male breast cancer?
MH Abreu, M Gomes, F Menezes, N Afonso, PH Abreu, R Medeiros, ...
The Breast 24 (4), 481-486, 2015
132015
Personalizing breast cancer patients with heterogeneous data
PH Abreu, H Amaro, DC Silva, P Machado, MH Abreu
The International Conference on Health Informatics, 39-42, 2014
122014
Tumor testing for somatic and germline BRCA1/BRCA2 variants in ovarian cancer patients in the context of strong founder effects
A Peixoto, P Pinto, J Guerra, M Pinheiro, C Santos, C Pinto, R Santos, ...
Frontiers in Oncology, 1318, 2020
92020
Neuro‐COVID frequency and short‐term outcome in the Northern Portuguese population
V Oliveira, M Seabra, R Rodrigues, V Carvalho, M Mendes, D Pereira, ...
European journal of neurology 28 (10), 3360-3368, 2021
82021
Recycling the purpose of old drugs to treat ovarian cancer
M Nunes, M Henriques Abreu, C Bartosch, S Ricardo
International journal of molecular sciences 21 (20), 7768, 2020
72020
Abstract CT219: neoadjuvant letrozole and palbociclib in stage II-IIIB HR [+]/HER2 [-] breast cancer with Oncotype DX Recurrence Score®(RS) 18-25 or 26-100. Analysis of RS …
AL Cussac, J Pérez-García, Á Guerrero, B Bermejo, M Gil, V Carañana, ...
Cancer Research 79 (13 Supplement), CT219-CT219, 2019
52019
Rectal cancer epidemiology
MH Abreu, FC Poças, R Rocha, J Pinto
Rectal Cancer—A Multidisciplinary Approach to Management 1, 2011
52011
European experts consensus: BRCA/homologous recombination deficiency testing in first-line ovarian cancer
I Vergote, A González-Martín, I Ray-Coquard, P Harter, N Colombo, ...
Annals of Oncology, 2021
42021
Allelic loss in amalgam‐associated oral lichenoid lesions compared to oral lichen planus and mucosa
LN Rodrigues, SF Sousa, RCC Silva, MHG Abreu, FR Pires, RA Mesquita, ...
Oral Diseases 23 (4), 471-476, 2017
42017
Staging and survival of rectal cancer in Vila Nova de Gaia, Portugal
MH Abreu, E Matos, FC Poças, R Rocha, J Pinto, C Lopes
European journal of gastroenterology & hepatology 22 (2), 151-156, 2010
42010
Abstract P5-23-01: Clinical and biological characterization of male breast cancer (BC) EORTC 10085/TBCRC 029/BOOG 2013-02/BIG 2-07: Baseline results from the prospective registry
SH Giordano, CP Schröder, C Poncet, E van Leeuwen-Stok, ...
Cancer Research 78 (4 Supplement), P5-23-01-P5-23-01, 2018
22018
536 Bevacizumab in cervical cancer–the experience of a comprehensive cancer center in northern Portugal
A Vaz-Ferreira, S Monteiro, AR Lopes, M Abreu, M Ferreira, S Sousa, ...
International Journal of Gynecologic Cancer 31 (Suppl 3), 2021
12021
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–20